US2507631A
(en)
|
1944-01-19 |
1950-05-16 |
Ciba Pharm Prod Inc |
Pyridine and piperidine compounds and process of making same
|
MC370A1
(fr)
|
1961-10-24 |
1963-03-28 |
American Cyanamid Co |
Procédé de préparation des aminotétracyclines substituées
|
GB993584A
(de)
|
1962-01-24 |
|
|
|
US3352912A
(en)
|
1963-07-24 |
1967-11-14 |
Du Pont |
Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes
|
GB1206403A
(en)
|
1966-12-15 |
1970-09-23 |
Wyeth John & Brother Ltd |
Oxazoles
|
US3674836A
(en)
|
1968-05-21 |
1972-07-04 |
Parke Davis & Co |
2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
|
GB1285035A
(en)
|
1968-11-09 |
1972-08-09 |
Conveyancer Ltd |
A power driven vehicle
|
US5562925A
(en)
|
1970-04-20 |
1996-10-08 |
Research Corporation Tech. Inc. |
Anti-tumor method
|
NL173848C
(nl)
|
1970-06-01 |
1984-03-16 |
Janssen Pharmaceutica Nv |
Werkwijze ter bereiding van 2.2-diaryl 4-piperidino butyramiden; werkwijze ter bereiding van therapeutisch werkzame preparaten en de door toepassing daarvan verkregen gevormde voortbrengselen.
|
DE2162555A1
(de)
|
1970-12-17 |
1972-06-22 |
Glaxo Laboratories Ltd., Greenford, Middlesex (Grossbritannien) |
Anästhetisch wirkende Steroidverbindungen
|
US3843681A
(en)
|
1971-06-01 |
1974-10-22 |
American Home Prod |
1-carboxamido pyrano(thiopyrano)(3,4-6)indole derivatives
|
DE2815926A1
(de)
|
1978-04-13 |
1979-10-18 |
Boehringer Mannheim Gmbh |
Neue carbazolyl-(4)-oxy-propanolamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
GB1415256A
(en)
|
1972-02-05 |
1975-11-26 |
Yamanouchi Pharma Co Ltd |
Alpha-aminomethylbenzyl alcohol derivatives
|
CH570401A5
(de)
|
1972-05-09 |
1975-12-15 |
Wander Ag Dr A |
|
FI54128C
(fi)
|
1972-12-09 |
1978-10-10 |
Akzo Nv |
Foerfarande foer framstaellning av nya 11,11-alkylidensteroider ur oestran- och 19-norpregnanserien med foerbaettrad hormonell verkan
|
US4314081A
(en)
|
1974-01-10 |
1982-02-02 |
Eli Lilly And Company |
Arloxyphenylpropylamines
|
US3965143A
(en)
|
1974-03-26 |
1976-06-22 |
G. D. Searle & Co. |
16-Oxygenated prostanoic acid derivatives
|
NL7503310A
(nl)
|
1975-03-20 |
1976-09-22 |
Philips Nv |
Verbindingen met antidepressieve werking.
|
GB1559811A
(en)
|
1975-07-28 |
1980-01-30 |
Sandoz Ltd |
Pharmaceutically active benzothiadiazole derivatives
|
US4026894A
(en)
|
1975-10-14 |
1977-05-31 |
Abbott Laboratories |
Antihypertensive agents
|
US4108880A
(en)
|
1975-11-03 |
1978-08-22 |
Johnson & Johnson |
Esters of retinoic acid
|
DE2644265C2
(de)
|
1976-09-30 |
1983-02-10 |
Bayer Ag, 5090 Leverkusen |
Chinazoline
|
GB1548022A
(en)
|
1976-10-06 |
1979-07-04 |
Wyeth John & Brother Ltd |
Pharmaceutial dosage forms
|
CH639659A5
(de)
|
1978-12-18 |
1983-11-30 |
Sandoz Ag |
Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
|
DK149855C
(da)
|
1977-06-20 |
1987-04-21 |
Sandoz Ag |
Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
|
GB1604739A
(en)
|
1977-07-28 |
1981-12-16 |
Yamanouchi Pharma Co Ltd |
7-methoxy-7-(1,3-dithietane-2-carboxamide) cephalosporanic acid derivatives
|
GB1591490A
(en)
|
1977-08-04 |
1981-06-24 |
Abbott Lab |
1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
|
US4820738A
(en)
|
1977-08-15 |
1989-04-11 |
American Cyanamid Company |
1,4-bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
|
US4278689A
(en)
|
1978-07-11 |
1981-07-14 |
American Cyanamid Company |
1,4-Bis(substituted-amino)-5,8-dihydroxy-anthraquinones and leuco bases thereof
|
GB2007656B
(en)
|
1977-11-05 |
1982-05-19 |
Pfizer Ltd |
Therapeutic agents
|
US4166182A
(en)
|
1978-02-08 |
1979-08-28 |
Eli Lilly And Company |
6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
|
CA1140119A
(en)
|
1978-04-03 |
1983-01-25 |
Joseph Torremans |
N-heterocyclyl-4-piperidinamines
|
DE2815578C2
(de)
|
1978-04-11 |
1986-01-16 |
Bayer Ag, 5090 Leverkusen |
Neue pharmazeutische Verwendung von Nimodipin
|
SE429652B
(sv)
|
1978-06-30 |
1983-09-19 |
Haessle Ab |
2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
|
US4323581A
(en)
|
1978-07-31 |
1982-04-06 |
Johnson & Johnson |
Method of treating carcinogenesis
|
US4307100A
(en)
|
1978-08-24 |
1981-12-22 |
Agence Nationale De Valorisation De La Recherche (Anvar) |
Nor bis-indole compounds usable as medicaments
|
US4356166A
(en)
|
1978-12-08 |
1982-10-26 |
University Of Utah |
Time-release chemical delivery system
|
DE2909439A1
(de)
|
1979-03-08 |
1980-09-18 |
Schering Ag |
Neue nichtionische roentgenkontrastmittel
|
US4642384A
(en)
|
1979-03-19 |
1987-02-10 |
Riker Laboratories, Inc. |
Process for the preparation of derivatives of pyrrolidine and piperidine
|
US4254129A
(en)
|
1979-04-10 |
1981-03-03 |
Richardson-Merrell Inc. |
Piperidine derivatives
|
CS234018B2
(en)
|
1979-06-01 |
1985-03-14 |
Wellcome Found |
Method of 3,5-diammino-6-1,2,4-triazine derivatives making
|
US4231938A
(en)
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
US5212326A
(en)
|
1979-08-20 |
1993-05-18 |
Abbott Laboratories |
Sodium hydrogen divalproate oligomer
|
US4988731A
(en)
|
1979-08-20 |
1991-01-29 |
Abbott Laboratories |
Sodium hydrogen divalproate oligomer
|
FR2465486A1
(fr)
|
1979-09-21 |
1981-03-27 |
Roussel Uclaf |
Nouvelle application utilisant la lh-rh ou des agonistes
|
US5389613A
(en)
|
1979-09-21 |
1995-02-14 |
Roussel Uclaf |
Method of treating prostate adenocarcinoma, prostate benign hypertrophia and endometriosis
|
US4536518A
(en)
|
1979-11-01 |
1985-08-20 |
Pfizer Inc. |
Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
|
DE19375086I2
(de)
|
1979-11-27 |
2003-01-09 |
Novartis Ag |
Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
|
ATE5202T1
(de)
|
1979-12-11 |
1983-11-15 |
Eisenwerk-Gesellschaft Maximilianshuette Mbh |
Stahlerzeugungsverfahren.
|
US4444784A
(en)
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
JPS56110665A
(en)
|
1980-02-08 |
1981-09-01 |
Yamanouchi Pharmaceut Co Ltd |
Sulfamoyl-substituted phenetylamine derivative and its preparation
|
GB2088877B
(en)
|
1980-02-15 |
1984-07-04 |
Glaxo Group Ltd |
Androstane 17 carbothioates
|
GB2078719B
(en)
|
1980-06-02 |
1984-04-26 |
Ici Ltd |
Heterocyclic compounds
|
US4331803A
(en)
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
US4301146A
(en)
|
1980-07-29 |
1981-11-17 |
G. D. Searle & Co. |
Stabilization of 16-oxygenated prostanoic acid derivatives
|
JPS5746986A
(en)
|
1980-09-02 |
1982-03-17 |
Dai Ichi Seiyaku Co Ltd |
Pyrido(1,2,3-de)(1,4)benzoxazine derivative
|
US4670444B1
(en)
|
1980-09-03 |
1999-02-09 |
Bayer Ag |
and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
|
US5264446A
(en)
|
1980-09-09 |
1993-11-23 |
Bayer Aktiengesellschaft |
Solid medicament formulations containing nifedipine, and processes for their preparation
|
US4486425A
(en)
|
1980-09-30 |
1984-12-04 |
Sankyo Company Limited |
7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
|
FR2492258A1
(fr)
|
1980-10-17 |
1982-04-23 |
Pharmindustrie |
Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
|
US4329356A
(en)
|
1980-10-31 |
1982-05-11 |
Eli Lilly And Company |
Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane
|
RO83309B
(ro)
|
1980-11-14 |
1984-02-28 |
Eli Lilly And Co |
Procedeu pentru prepararea (-)-n-metil-3-(2-metil-fenoxi)-3-fenilpropilaminei
|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
US4384123A
(en)
|
1980-12-04 |
1983-05-17 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted prolines
|
US4337201A
(en)
|
1980-12-04 |
1982-06-29 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted prolines
|
US4308264A
(en)
|
1981-01-28 |
1981-12-29 |
Abbott Laboratories |
Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
|
NO155805C
(no)
|
1981-02-06 |
1987-06-10 |
Ucb Sa |
Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
|
US4526892A
(en)
|
1981-03-03 |
1985-07-02 |
Farmitalia Carlo Erba, S.P.A. |
Dimethylaminoalkyl-3-(ergoline-8'βcarbonyl)-ureas
|
YU43006B
(en)
|
1981-03-06 |
1989-02-28 |
Pliva Pharm & Chem Works |
Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
|
US4418068A
(en)
|
1981-04-03 |
1983-11-29 |
Eli Lilly And Company |
Antiestrogenic and antiandrugenic benzothiophenes
|
US4355032B2
(en)
|
1981-05-21 |
1990-10-30 |
|
9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
|
US4507305A
(en)
|
1981-05-21 |
1985-03-26 |
Syntex (U.S.A.) Inc. |
9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
|
US4423050A
(en)
|
1981-05-21 |
1983-12-27 |
Syntex (U.S.A.) Inc. |
9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
|
DE3262386D1
(en)
|
1981-06-06 |
1985-03-28 |
Pfizer Ltd |
Antifungal agents, processes for their preparation, and pharmaceutical compositions containing them
|
US4962115A
(en)
|
1981-10-01 |
1990-10-09 |
Janssen Pharmaceutica N.V. |
Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives
|
US4410520A
(en)
|
1981-11-09 |
1983-10-18 |
Ciba-Geigy Corporation |
3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
|
DK161312C
(da)
|
1982-03-11 |
1991-12-09 |
Pfizer |
Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
|
IT1201087B
(it)
|
1982-04-15 |
1989-01-27 |
Gentili Ist Spa |
Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
|
GR79215B
(de)
|
1982-06-07 |
1984-10-22 |
Glaxo Group Ltd |
|
US4519801A
(en)
|
1982-07-12 |
1985-05-28 |
Alza Corporation |
Osmotic device with wall comprising cellulose ether and permeability enhancer
|
LU88769I2
(fr)
|
1982-07-23 |
1996-11-05 |
Zeneca Ltd |
Bicalutamide et ses sels et esters pharmaceutiquement acceptables (Casodex (R))
|
JPS5951288A
(ja)
|
1982-09-17 |
1984-03-24 |
Yakult Honsha Co Ltd |
新規な9−ニトロカンプトテシン及びその製造法
|
DK162718C
(da)
|
1982-09-30 |
1992-05-11 |
Fujisawa Pharmaceutical Co |
Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser
|
EP0108638B1
(de)
|
1982-11-08 |
1986-07-16 |
NYEGAARD & CO. A/S |
Röntgenkontrastmittel
|
US4535186A
(en)
|
1983-04-19 |
1985-08-13 |
American Home Products Corporation |
2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
|
US4520022A
(en)
|
1983-01-28 |
1985-05-28 |
Bristol-Myers Company |
Substituted vinyl cephalosporins
|
US5053432A
(en)
|
1983-04-14 |
1991-10-01 |
Burroughs Wellcome Co. |
Naphthoquinone derivatives
|
CA1283906C
(en)
|
1983-05-09 |
1991-05-07 |
Makoto Sunagawa |
.beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
|
US5082668A
(en)
|
1983-05-11 |
1992-01-21 |
Alza Corporation |
Controlled-release system with constant pushing source
|
US4612008A
(en)
|
1983-05-11 |
1986-09-16 |
Alza Corporation |
Osmotic device with dual thermodynamic activity
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
US4567264A
(en)
|
1983-05-18 |
1986-01-28 |
Syntex (U.S.A.) Inc. |
Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
|
CA1237079A
(en)
|
1983-05-23 |
1988-05-24 |
Arthur Simon |
Antiarrhythmic class iii process
|
JPS6019790A
(ja)
|
1983-07-14 |
1985-01-31 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体
|
USRE33994E
(en)
|
1983-08-16 |
1992-07-14 |
Burroughs Wellcome Co. |
Pharmaceutical delivery system
|
CH656884A5
(de)
|
1983-08-26 |
1986-07-31 |
Sandoz Ag |
Polyolester, deren herstellung und verwendung.
|
JPS6051189A
(ja)
|
1983-08-30 |
1985-03-22 |
Sankyo Co Ltd |
チアゾリジン誘導体およびその製造法
|
US4513006A
(en)
|
1983-09-26 |
1985-04-23 |
Mcneil Lab., Inc. |
Anticonvulsant sulfamate derivatives
|
AU575854B2
(en)
|
1983-10-04 |
1988-08-11 |
Shionogi & Co., Ltd. |
7beta-(carboxyalkenamido) cephalosporins
|
JPS60100516A
(ja)
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
SE8306367L
(sv)
|
1983-11-18 |
1985-05-19 |
Ferring Ab |
Antidiuretiskt verkande farmaceutiskt preparat
|
US5238924A
(en)
|
1984-05-03 |
1993-08-24 |
Merck & Co., Inc. |
Treatment of renal diseases with ace inhibitors
|
US4551552A
(en)
|
1984-05-23 |
1985-11-05 |
E. I. Du Pont De Nemours And Company |
Process for preparing rimantadine
|
GB8419575D0
(en)
|
1984-08-01 |
1984-09-05 |
Glaxo Group Ltd |
Chemical compounds
|
US4639338A
(en)
|
1984-08-06 |
1987-01-27 |
Ciba-Geigy Corporation |
Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
|
DE3582399D1
(de)
|
1984-09-20 |
1991-05-08 |
Beecham Group Plc |
Purin-derivate und ihre pharmazeutische verwendung.
|
DE3581471D1
(de)
|
1984-10-19 |
1991-02-28 |
Battelle Memorial Institute |
Durch mikroorganismen abbaubares polypeptid und seine verwendung fuer die fortschreitende abgabe von medikamenten.
|
ATE45735T1
(de)
|
1984-12-22 |
1989-09-15 |
Thomae Gmbh Dr K |
Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
|
US4772475A
(en)
|
1985-03-08 |
1988-09-20 |
Yamanouchi Pharmaceutical Co., Ltd. |
Controlled-release multiple units pharmaceutical formulation
|
DE3608606A1
(de)
|
1985-03-16 |
1986-09-18 |
The Wellcome Foundation Ltd., London |
3'-azido-3'-deoxythymidin oder eine, ein pharmazeutisch vertraegliches derivat davon enthaltende pharmazeutische formulierung, verfahren zu ihrer herstellung und ihre verwendung
|
US4724232A
(en)
|
1985-03-16 |
1988-02-09 |
Burroughs Wellcome Co. |
Treatment of human viral infections
|
US4665098A
(en)
|
1985-03-28 |
1987-05-12 |
Mcneilab, Inc. |
Pharmaceutical composition of N-(4-hydroxyphenyl) retinamide having increased bioavailability
|
DK170473B1
(da)
|
1985-06-20 |
1995-09-11 |
Daiichi Seiyaku Co |
S(-)-pyridobenzoxazinforbindelser
|
US4642346A
(en)
|
1985-06-24 |
1987-02-10 |
Syntex (U.S.A.) Inc. |
Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
|
DK288385D0
(da)
|
1985-06-26 |
1985-06-26 |
Novo Industri As |
Aminosyrederivater
|
DE3529529A1
(de)
|
1985-08-17 |
1987-02-19 |
Boehringer Mannheim Gmbh |
Verfahren zur herstellung einer stabilen modifikation von torasemid
|
WO1987001284A1
(en)
|
1985-08-26 |
1987-03-12 |
United States Of America, Represented By The Unite |
Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
|
US5254539A
(en)
|
1985-08-26 |
1993-10-19 |
U.S. Government, Dept. Of Health And Human Services, C/O National Institutes Of Health |
Method of treating HIV with 2',3'-dideoxyinosine
|
US5246937A
(en)
|
1985-09-18 |
1993-09-21 |
Beecham Group P.L.C. |
Purine derivatives
|
GB8524663D0
(en)
|
1985-10-07 |
1985-11-13 |
Fujisawa Pharmaceutical Co |
Quinazoline derivatives
|
ES2058061T3
(es)
|
1985-10-25 |
1994-11-01 |
Beecham Group Plc |
Derivado de piperidina, su preparacion y su uso como medicamento.
|
DE3543999A1
(de)
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Hochreine acarbose
|
IT1188212B
(it)
|
1985-12-20 |
1988-01-07 |
Paolo Colombo |
Sistema per il rilascio a velocita' controllata di sostanze attive
|
EP0254737B1
(de)
|
1986-01-16 |
1990-07-25 |
Schering Corporation |
Kondensierte benzazepine
|
US5286754A
(en)
|
1986-01-21 |
1994-02-15 |
Bayer Aktiengesellschaft |
Pharmaceutical formulations of ciprofloxacin
|
GB8607684D0
(en)
|
1986-03-27 |
1986-04-30 |
Ici America Inc |
Thiazepine compounds
|
GB8608335D0
(en)
|
1986-04-04 |
1986-05-08 |
Pfizer Ltd |
Pharmaceutically acceptable salts
|
SE8601624D0
(sv)
|
1986-04-11 |
1986-04-11 |
Haessle Ab |
New pharmaceutical preparations
|
US4826868A
(en)
|
1986-05-29 |
1989-05-02 |
Ortho Pharmaceutical Corporation |
1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
|
US4681893A
(en)
|
1986-05-30 |
1987-07-21 |
Warner-Lambert Company |
Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
|
US4940727A
(en)
|
1986-06-23 |
1990-07-10 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
USRE36481E
(en)
|
1986-06-23 |
2000-01-04 |
Merck & Co., Inc. |
HMG-CoA reductase inhibitors
|
US5138069A
(en)
|
1986-07-11 |
1992-08-11 |
E. I. Du Pont De Nemours And Company |
Angiotensin II receptor blocking imidazoles
|
DE3623620A1
(de)
|
1986-07-12 |
1988-01-21 |
Boehringer Mannheim Gmbh |
Spritzfertige, waessrige, alkalische injektionsloesungen von torasemid und verfahren zu ihrer herstellung
|
FR2601675B1
(fr)
|
1986-07-17 |
1988-09-23 |
Rhone Poulenc Sante |
Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
|
IE60588B1
(en)
|
1986-07-30 |
1994-07-27 |
Sumitomo Pharma |
Carbapenem compound in crystalline form, and its production and use
|
IN165717B
(de)
|
1986-08-07 |
1989-12-23 |
Battelle Memorial Institute |
|
DE3639353A1
(de)
|
1986-11-18 |
1988-05-19 |
Huels Chemische Werke Ag |
Ester von 3-tert.butyl- bzw. 3-tert.butyl-5-alkyl-4-hydroxyphenyl-(alkan-)carbonsaeuren mit oxethylaten von polythiolen, verfahren zu ihrer herstellung und ihre verwendung als stabilisatoren
|
KR880007441A
(ko)
|
1986-12-11 |
1988-08-27 |
알렌 제이.스피겔 |
스피로-치환된 글루타르아미드 이뇨제
|
US4978655A
(en)
|
1986-12-17 |
1990-12-18 |
Yale University |
Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
|
KR880007433A
(ko)
|
1986-12-22 |
1988-08-27 |
메리 앤 터커 |
3-아릴옥시-3-치환된 프로판아민
|
US4753935A
(en)
|
1987-01-30 |
1988-06-28 |
Syntex (U.S.A.) Inc. |
Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
|
IL84305A
(en)
|
1987-02-06 |
1992-01-15 |
Fisons Corp |
2-aminoacetamide derivatives
|
US4826860A
(en)
|
1987-03-16 |
1989-05-02 |
Warner-Lambert Company |
Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
|
GB8708886D0
(en)
|
1987-04-14 |
1987-05-20 |
Akzo Nv |
2beta-morpholino-androstane derivatives
|
US4808411A
(en)
|
1987-06-05 |
1989-02-28 |
Abbott Laboratories |
Antibiotic-polymer compositions
|
DE3720757A1
(de)
|
1987-06-24 |
1989-01-05 |
Bayer Ag |
Dhp-manteltablette
|
US4997841A
(en)
|
1987-08-13 |
1991-03-05 |
Glaxo Group Limited |
Indole derivatives
|
GB8719367D0
(en)
|
1987-08-15 |
1987-09-23 |
Wellcome Found |
Therapeutic compounds
|
ZA885709B
(en)
|
1987-08-19 |
1989-04-26 |
Fujisawa Pharmaceutical Co |
Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
|
US5232917A
(en)
|
1987-08-25 |
1993-08-03 |
University Of Southern California |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
|
FR2619713B1
(fr)
|
1987-08-25 |
1990-08-31 |
Rhone Poulenc Sante |
Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement des troubles du sommeil et de la depression
|
IE60311B1
(en)
|
1987-09-24 |
1994-06-29 |
American Home Prod |
Sustained release etodolac
|
US4797405A
(en)
|
1987-10-26 |
1989-01-10 |
Eli Lilly And Company |
Stabilized pergolide compositions
|
CA1327358C
(en)
|
1987-11-17 |
1994-03-01 |
Morio Fujiu |
Fluoro cytidine derivatives
|
US5004758A
(en)
|
1987-12-01 |
1991-04-02 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
|
US5382600A
(en)
|
1988-01-22 |
1995-01-17 |
Pharmacia Aktiebolag |
3,3-diphenylpropylamines and pharmaceutical compositions thereof
|
ATE113054T1
(de)
|
1988-02-02 |
1994-11-15 |
Johnson Matthey Inc |
Pt(iv) komplexe.
|
US5047407A
(en)
|
1989-02-08 |
1991-09-10 |
Iaf Biochem International, Inc. |
2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
|
GB8815265D0
(en)
|
1988-06-27 |
1988-08-03 |
Wellcome Found |
Therapeutic nucleosides
|
DE3901814A1
(de)
|
1988-07-28 |
1990-02-01 |
Bayer Ag |
Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
|
GB8819477D0
(en)
|
1988-08-16 |
1988-09-21 |
Wellcome Found |
Medicaments
|
US5114976A
(en)
|
1989-01-06 |
1992-05-19 |
Norden Michael J |
Method for treating certain psychiatric disorders and certain psychiatric symptoms
|
US5246925A
(en)
|
1989-03-09 |
1993-09-21 |
Wisconsin Alumni Research Foundation |
19-nor-vitamin D compounds for use in treating hyperparathyroidism
|
CA1333616C
(en)
|
1989-03-09 |
1994-12-20 |
Hector F. Deluca |
19-nor-vitamin d compounds
|
US5354866A
(en)
|
1989-05-23 |
1994-10-11 |
Abbott Laboratories |
Retroviral protease inhibiting compounds
|
US5696270A
(en)
|
1989-05-23 |
1997-12-09 |
Abbott Laboratories |
Intermediate for making retroviral protease inhibiting compounds
|
US5686567A
(en)
|
1989-06-16 |
1997-11-11 |
Cor Therapeutics, Inc. |
Platelet aggregation inhibitors
|
US5538739A
(en)
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
PH30995A
(en)
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
US5006344A
(en)
|
1989-07-10 |
1991-04-09 |
E. R. Squibb & Sons, Inc. |
Fosinopril tablet formulations
|
FI94339C
(fi)
|
1989-07-21 |
1995-08-25 |
Warner Lambert Co |
Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
|
HU225965B1
(en)
|
1989-09-18 |
2008-01-28 |
Stanford Res Inst Int |
Process for producing medicaments containing 1,2,4-benzotriazine oxides as radiation sensitizers and/or selective cytotoxic agents
|
FR2653017B1
(fr)
|
1989-10-17 |
1995-05-05 |
Delalande Sa |
Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
|
US5114948A
(en)
|
1989-10-19 |
1992-05-19 |
Eli Lilly And Company |
Stabilized pergolide compositions
|
GB8924528D0
(en)
|
1989-10-31 |
1989-12-20 |
Wellcome Found |
Heterocyclic pharmaceutical compounds,preparation and use
|
US4962128A
(en)
|
1989-11-02 |
1990-10-09 |
Pfizer Inc. |
Method of treating anxiety-related disorders using sertraline
|
IL96531A
(en)
|
1989-12-11 |
1995-08-31 |
Univ Princeton |
History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)
|
GB8927913D0
(en)
|
1989-12-11 |
1990-02-14 |
Hoffmann La Roche |
Amino acid derivatives
|
IT1237904B
(it)
|
1989-12-14 |
1993-06-18 |
Ubaldo Conte |
Compresse a rilascio a velocita' controllata delle sostanze attive
|
GB9002375D0
(en)
|
1990-02-02 |
1990-04-04 |
Pfizer Ltd |
Triazole antifungal agents
|
MY107937A
(en)
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
EP0443983B1
(de)
|
1990-02-19 |
1996-02-28 |
Ciba-Geigy Ag |
Acylverbindungen
|
US5229382A
(en)
|
1990-04-25 |
1993-07-20 |
Lilly Industries Limited |
2-methyl-thieno-benzodiazepine
|
ES2071312T3
(es)
|
1990-05-03 |
1995-06-16 |
Searle & Co |
Composicion farmaceutica.
|
YU48855B
(sh)
|
1990-06-07 |
2002-06-19 |
The Wellcome Foundation Limited |
Heterociklična jedinjenja i njihovi derivati koji su modifikatori dejstva 5-hidroksi-triptamina i postupak njihovog dobijanja
|
US5212176A
(en)
|
1990-06-29 |
1993-05-18 |
Abbott Laboratories |
R(+)-terazosin
|
GR1001529B
(el)
|
1990-09-07 |
1994-03-31 |
Elmuquimica Farm Sl |
Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
|
EP0477931B1
(de)
*
|
1990-09-28 |
1994-08-17 |
Mercian Corporation |
Adriamycinderivate
|
US5238714A
(en)
|
1990-10-02 |
1993-08-24 |
Board Of Regents, The University Of Texas System |
Efficient microcapsule preparation and method of use
|
US5565473A
(en)
|
1990-10-12 |
1996-10-15 |
Merck Frosst Canada, Inc. |
Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
|
US5177080A
(en)
|
1990-12-14 |
1993-01-05 |
Bayer Aktiengesellschaft |
Substituted pyridyl-dihydroxy-heptenoic acid and its salts
|
CZ283018B6
(cs)
|
1991-02-01 |
1997-12-17 |
Merck Sharp And Dohme Limited |
Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
|
DE69230372T2
(de)
|
1991-03-19 |
2000-06-15 |
Cytrx Corp |
Polyoxypropylen/polyoxyethylen copolymere mit verbesserter biologischer aktivität
|
AU654331B2
(en)
|
1991-03-30 |
1994-11-03 |
Kissei Pharmaceutical Co. Ltd. |
Succinic acid compounds
|
DK58291D0
(da)
|
1991-04-02 |
1991-04-02 |
Novo Nordisk As |
Krystalinsk stof og dets fremstilling
|
US5605897A
(en)
|
1991-04-23 |
1997-02-25 |
Eli Lilly And Company |
2-methyl-thieno-benzodiazepine
|
GB9111902D0
(en)
|
1991-06-03 |
1991-07-24 |
Glaxo Group Ltd |
Chemical compounds
|
RU2086544C1
(ru)
|
1991-06-13 |
1997-08-10 |
Хоффманн-Ля Рош АГ |
Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
|
CA2068402C
(en)
|
1991-06-14 |
1998-09-22 |
Michael R. Hoy |
Taste mask coatings for preparation of chewable pharmaceutical tablets
|
AU660930B2
(en)
|
1991-06-21 |
1995-07-13 |
Novo Nordisk A/S |
(S)(+)-2-ethoxy-4-(N-(1-(2-piperidinophenyl)-3-methyl-1- butyl)aminocarbonylmethyl)benzoic acid
|
FR2678833B1
(fr)
|
1991-07-08 |
1995-04-07 |
Rhone Poulenc Rorer Sa |
Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
|
WO1993000897A1
(en)
|
1991-07-12 |
1993-01-21 |
Warner-Lambert Company |
Cholecystokinin antagonists useful in the treatment of panic attacks
|
EP0603312A4
(de)
|
1991-09-13 |
1995-06-07 |
Cocensys Inc |
Neuer gaba a-rezeptor mit steroidbindungsstellen.
|
US5252602A
(en)
|
1991-10-11 |
1993-10-12 |
Rafeul Alam |
Effects of misoprostol on allergic responses
|
US5413999A
(en)
|
1991-11-08 |
1995-05-09 |
Merck & Co., Inc. |
HIV protease inhibitors useful for the treatment of AIDS
|
DK0541168T3
(da)
|
1991-11-08 |
1998-05-11 |
Merck & Co Inc |
HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
|
GB9202298D0
(en)
|
1992-02-04 |
1992-03-18 |
Ici Plc |
Antibiotic compounds
|
WO1993019749A1
(en)
|
1992-04-02 |
1993-10-14 |
Smithkline Beecham Corporation |
Compounds useful for treating allergic and inflammatory diseases
|
FR2689888B1
(fr)
|
1992-04-10 |
1994-06-10 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
GB9209599D0
(en)
|
1992-05-02 |
1992-06-17 |
Fisons Corp |
Novel therapy for the treatment of parkinsons disease
|
JPH07506828A
(ja)
|
1992-05-11 |
1995-07-27 |
メレルダウファーマス−ティカルズ インコーポレイテッド |
肝臓が損われた患者での抗ヒスタミン剤としてのターフェナジン誘導体の用途
|
RU2124503C1
(ru)
|
1992-05-18 |
1999-01-10 |
И.Р.Сквибб энд Санз, Инк. |
Гетероциклические азотсодержащие производные карбоновой кислоты, способ их получения и фармацевтическая композиция
|
MY113693A
(en)
|
1992-05-26 |
2002-05-31 |
Chugai Pharmaceutical Co Ltd |
Erythromycin derivatives having an enterokinesis stimulating action
|
US5534496A
(en)
*
|
1992-07-07 |
1996-07-09 |
University Of Southern California |
Methods and compositions to enhance epithelial drug transport
|
GB9215665D0
(en)
|
1992-07-23 |
1992-09-09 |
British Bio Technology |
Compounds
|
TW366342B
(en)
|
1992-07-28 |
1999-08-11 |
Lilly Co Eli |
The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
|
MX9304638A
(es)
|
1992-07-31 |
1994-05-31 |
Neose Pharm Inc |
Composicion para tratar e inhibir las ulceras gastricas y duodenales.
|
US5424471A
(en)
|
1992-07-31 |
1995-06-13 |
U.S. Bioscience, Inc. |
Crystalline amifostine compositions and methods of the preparation and use of same
|
SG47101A1
(en)
|
1992-07-31 |
1998-03-20 |
Us Bioscience |
Crystalline amifostine compositions and methods for the preparation and use of same
|
CA2086874E
(en)
|
1992-08-03 |
2000-01-04 |
Renzo Mauro Canetta |
Methods for administration of taxol
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
US5248699A
(en)
|
1992-08-13 |
1993-09-28 |
Pfizer Inc. |
Sertraline polymorph
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
JP3277342B2
(ja)
|
1992-09-02 |
2002-04-22 |
武田薬品工業株式会社 |
徐放性マイクロカプセルの製造法
|
AU687746B2
(en)
|
1992-09-03 |
1998-03-05 |
Sepracor, Inc. |
Use of norastemizole for the treatment of allergic disorders
|
US5723490A
(en)
|
1992-09-08 |
1998-03-03 |
Vertex Pharmaceuticals Incorporated |
THF-containing sulfonamide inhibitors of aspartyl protease
|
IS2334B
(is)
|
1992-09-08 |
2008-02-15 |
Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) |
Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
|
SE9203318D0
(sv)
|
1992-11-06 |
1992-11-06 |
Kabi Pharmacia Ab |
Novel 3,3-diphenylpropylamines, their use and preparation
|
DE69324106T2
(de)
|
1992-11-17 |
1999-12-09 |
Sankyo Co |
Krystallines Carbapenemderivat
|
US5358941A
(en)
|
1992-12-02 |
1994-10-25 |
Merck & Co., Inc. |
Dry mix formulation for bisphosphonic acids with lactose
|
AU671491B2
(en)
|
1992-12-18 |
1996-08-29 |
F. Hoffmann-La Roche Ag |
N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
|
US5484926A
(en)
|
1993-10-07 |
1996-01-16 |
Agouron Pharmaceuticals, Inc. |
HIV protease inhibitors
|
KR100333016B1
(ko)
|
1992-12-29 |
2002-11-22 |
아보트 러보러터리즈 |
레트로바이러스성프로테아제억제화합물,이의제조방법및이를함유하는약제학적조성물
|
CA2150372C
(en)
|
1993-01-19 |
2002-08-20 |
Nancy L. Mills |
Stable oral ci-981 formulation and process of preparing same
|
US5298410A
(en)
*
|
1993-02-25 |
1994-03-29 |
Sterling Winthrop Inc. |
Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life
|
US5378804A
(en)
|
1993-03-16 |
1995-01-03 |
Merck & Co., Inc. |
Aza cyclohexapeptide compounds
|
US5294615A
(en)
|
1993-04-29 |
1994-03-15 |
Abbott Laboratories |
Terazosin polymorph and pharmaceutical composition
|
AU698834B2
(en)
|
1993-05-24 |
1998-11-12 |
Purdue Pharma Ltd. |
Methods and compositions for inducing sleep
|
US5891459A
(en)
*
|
1993-06-11 |
1999-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
|
AU670004B2
(en)
|
1993-06-24 |
1996-06-27 |
Albany Molecular Research, Inc. |
Piperidine derivatives and process for their production
|
US5674850A
(en)
|
1993-12-23 |
1997-10-07 |
Ferring Ab |
High purity desmopressin produced in large single batches
|
US5500413A
(en)
|
1993-06-29 |
1996-03-19 |
Ferring Ab |
Process for manufacture of 1-deamino-8-D-arginine vasopressin
|
US5698226A
(en)
|
1993-07-13 |
1997-12-16 |
Glaxo Wellcome Inc. |
Water-dispersible tablets
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
US5667775A
(en)
|
1993-08-11 |
1997-09-16 |
Geltex Pharmaceuticals, Inc. |
Phosphate-binding polymers for oral administration
|
US5496545A
(en)
|
1993-08-11 |
1996-03-05 |
Geltex Pharmaceuticals, Inc. |
Phosphate-binding polymers for oral administration
|
TW406020B
(en)
|
1993-09-29 |
2000-09-21 |
Bristol Myers Squibb Co |
Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
|
US5457895A
(en)
|
1993-10-01 |
1995-10-17 |
R. P. Scherer Corporation |
Method of identifying freeze-dried dosage forms
|
PT725642E
(pt)
|
1993-10-27 |
2000-05-31 |
Upjohn Co |
Prostaglandina e 1 estabilizada
|
CO4520281A1
(es)
|
1993-12-21 |
1997-10-15 |
Schering Corp |
Antifungicos de tetrahidrofurano
|
IL111991A
(en)
|
1994-01-28 |
2000-07-26 |
Abbott Lab |
Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
|
US5972383A
(en)
|
1994-03-02 |
1999-10-26 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
US5811120A
(en)
|
1994-03-02 |
1998-09-22 |
Eli Lilly And Company |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
|
US5478847A
(en)
|
1994-03-02 |
1995-12-26 |
Eli Lilly And Company |
Methods of use for inhibiting bone loss and lowering serum cholesterol
|
CA2145614A1
(en)
|
1994-03-31 |
1995-10-01 |
Jeffrey A. Dodge |
Intermediates and processes for preparing benzothiophene compounds
|
US5466810A
(en)
|
1994-06-10 |
1995-11-14 |
Eli Lilly And Company |
2-amino-3-aroyl-benzo[β]thiophenes and methods for preparing and using same to produce 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-aminoethoxy)-benzoyl]benzo[β]thiophenes
|
ZA956647B
(en)
|
1994-08-10 |
1997-02-10 |
Wellcome Found |
Hypolipidaemic compounds.
|
CO4410191A1
(es)
|
1994-09-19 |
1997-01-09 |
Lilly Co Eli |
SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
|
US5629425A
(en)
|
1994-09-19 |
1997-05-13 |
Eli Lilly And Company |
Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
|
US5681950A
(en)
|
1994-09-28 |
1997-10-28 |
Universidad De Antioquia |
Withajardins
|
CN1203089C
(zh)
|
1994-10-07 |
2005-05-25 |
藤泽药品工业株式会社 |
新化合物
|
US5910569A
(en)
*
|
1994-11-22 |
1999-06-08 |
Lotus Biochemical Corporation |
Iodothyronine polymers
|
CA2163837C
(en)
|
1994-12-13 |
1999-07-20 |
Robert K. Perrone |
Crystalline paclitaxel hydrates
|
US5856493A
(en)
|
1995-02-06 |
1999-01-05 |
Smithkline Beecham Corporation |
Process for making novel form of paroxeting hydrochloride anhydrate
|
US5760069A
(en)
|
1995-02-08 |
1998-06-02 |
Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 |
Method of treatment for decreasing mortality resulting from congestive heart failure
|
WO1996025405A1
(en)
|
1995-02-13 |
1996-08-22 |
G.D. Searle & Co. |
Substituted isoxazoles for the treatment of inflammation
|
GB9502858D0
(en)
|
1995-02-14 |
1995-04-05 |
British Biotech Pharm |
Novel use of matrix metalloproteinase inhibitors
|
KR19980702210A
(ko)
|
1995-02-17 |
1998-07-15 |
폴락 돈나 엘 |
비척추골 골절의 위험률을 감소시키는 방법
|
AU701042B2
(en)
|
1995-02-28 |
1999-01-21 |
Aventisub Llc |
Pharmaceutical composition for piperidinoalkanol compounds
|
EG23659A
(en)
|
1995-03-24 |
2007-03-26 |
Lilly Co Eli |
Process and crystal forms of methyl-thieno-benzodiazepine
|
CR5278A
(es)
|
1995-03-24 |
1996-07-04 |
Lilly Co Eli |
Formulacion oral de 2-metil-tieno-benzodiacepina
|
US5614639A
(en)
|
1995-03-31 |
1997-03-25 |
Eli Lilly And Company |
Process for preparing 2-substituted benzo[b]thiophene compounds and intermediates thereof
|
US5674895A
(en)
|
1995-05-22 |
1997-10-07 |
Alza Corporation |
Dosage form comprising oxybutynin
|
US5912268A
(en)
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
CA2221417C
(en)
|
1995-06-06 |
2002-04-30 |
Merck & Co., Inc. |
Anhydrous alendronate monosodium salt formulations
|
US5514826A
(en)
|
1995-06-07 |
1996-05-07 |
Eli Lilly And Company |
Vinyl sulfenic acid derivatives
|
US5659087A
(en)
|
1995-06-07 |
1997-08-19 |
Eli Lilly And Company |
Diarylvinyl sulfoxides
|
US5569772A
(en)
|
1995-06-07 |
1996-10-29 |
Eli Lilly And Company |
Process for the synthesis of benzo[b]thiophenes
|
IL118279A
(en)
|
1995-06-07 |
2006-10-05 |
Abbott Lab |
Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission
|
US6037157A
(en)
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
CZ294740B6
(cs)
|
1995-07-17 |
2005-03-16 |
Warner-Lambert Company |
Krystalická forma IV atorvastatinu nebo jeho hydrátu, farmaceutický přípravek obsahující tuto krystalickou formu IV atorvastatinu a její použití v lékařství
|
US5762909A
(en)
|
1995-08-31 |
1998-06-09 |
General Electric Company |
Tumor targeting with polymeric molecules having extended conformation
|
GB9518027D0
(en)
|
1995-09-05 |
1995-11-08 |
Wellcome Found |
Pharmacologically active compound
|
US5851536A
(en)
|
1995-11-22 |
1998-12-22 |
University Of Washington |
Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
|
US5922736A
(en)
|
1995-12-04 |
1999-07-13 |
Celegene Corporation |
Chronic, bolus administration of D-threo methylphenidate
|
US5646180A
(en)
|
1995-12-05 |
1997-07-08 |
Vertex Pharmaceuticals Incorporated |
Treatment of the CNS effects of HIV
|
US5753653A
(en)
|
1995-12-08 |
1998-05-19 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
EP0869974B1
(de)
|
1995-12-22 |
2009-03-04 |
Novo Nordisk A/S |
Verbindungen mit wachstumshormon-freisetzenden eigenschaften
|
US5731342A
(en)
|
1996-02-22 |
1998-03-24 |
Eli Lilly And Company |
Benzothiophenes, formulations containing same, and methods
|
CN1304058C
(zh)
|
1996-03-12 |
2007-03-14 |
Pg-Txl有限公司 |
水溶性紫杉醇产品
|
US6030941A
(en)
*
|
1996-05-01 |
2000-02-29 |
Avi Biopharma, Inc. |
Polymer composition for delivering substances in living organisms
|
WO1997040854A2
(en)
*
|
1996-05-01 |
1997-11-06 |
Antivirals Inc. |
Polypeptide conjugates for transporting substances across cell membranes
|
US5843984A
(en)
|
1996-05-09 |
1998-12-01 |
Eli Lilly And Company |
Sulfated benzothiophene derivatives, methods of use and formulations containing same
|
US5763398A
(en)
|
1996-06-20 |
1998-06-09 |
Ferring B.V. |
Nasal administration of desmopressin
|
US5952294A
(en)
*
|
1996-07-31 |
1999-09-14 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptidyl prodrugs and methods of making and using the same
|
NZ334274A
(en)
|
1996-09-04 |
2001-02-23 |
Abbott Lab |
6-o-substituted ketolides having antibacterial activity
|
HRP970566A2
(en)
*
|
1996-10-30 |
1998-08-31 |
Jones Deborah Defeo |
Conjugates useful in the treatment of prostate canser
|
US5948750A
(en)
|
1996-10-30 |
1999-09-07 |
Merck & Co., Inc. |
Conjugates useful in the treatment of prostate cancer
|
US6113920A
(en)
|
1996-10-31 |
2000-09-05 |
Glaxo Wellcome Inc. |
Pharmaceutical compositions
|
JP2002502376A
(ja)
|
1997-05-21 |
2002-01-22 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
生物学的膜を横切る輸送を増強するための組成物および方法
|
US5922877A
(en)
|
1997-08-05 |
1999-07-13 |
The Stehlin Foundation For Cancer Research |
Methods of preparing and purifying 9-nitro-20-camptothecin
|
US5994409A
(en)
|
1997-12-09 |
1999-11-30 |
U.S. Bioscience, Inc. |
Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
|
US6485514B1
(en)
|
1997-12-12 |
2002-11-26 |
Supergen, Inc. |
Local delivery of therapeutic agents
|
CH689805A8
(fr)
|
1998-07-02 |
2000-02-29 |
Smithkline Beecham Plc |
Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
|
US6008207A
(en)
|
1998-08-13 |
1999-12-28 |
Merck & Co., Inc. |
Anhydrous alendronate monosodium salt formulations
|
US6309633B1
(en)
*
|
1999-06-19 |
2001-10-30 |
Nobex Corporation |
Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
|
US6051567A
(en)
|
1999-08-02 |
2000-04-18 |
Abbott Laboratories |
Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
|
JP2003516206A
(ja)
*
|
1999-12-07 |
2003-05-13 |
クラスノウ インスティテュート |
神経系の適応性電場調整
|
JP2004523480A
(ja)
*
|
2000-08-22 |
2004-08-05 |
ニュー リバー ファーマシューティカルズ, インコーポレイテッド |
活性作用物質送達系ならびに活性作用物質の保護および投与方法
|
JP2006516947A
(ja)
*
|
2000-11-16 |
2006-07-13 |
ニュー リバー ファーマシューティカルズ インコーポレイテッド |
新規な医薬化合物およびその製造方法と使用方法
|